Lupin Limited announced the appointment of Alok Sonig as CEO - US Generics and Global Head - Generics R&D & Biosimilars. Alok will lead and have overall responsibility for the US Generics business including Research & Development in India and the US and the Commercial side of the business in the US. He will also be responsible for Lupin's global Biosimilars business.
With over 23 years of experience in the industry, Alok brings an established track record of success in the Pharmaceutical and Healthcare sectors to Lupin. Most recently, Alok was CEO of Developed Markets (US, Canada, Europe and Japan) at Dr. Reddy's. He joined Dr. Reddy's in 2012 and ran their India business till 2015 before moving back to the US to run their North America business. Prior to Dr. Reddy's, Alok spent nearly 15 years at Bristol-Myers Squibb, where he held several positions of increasing responsibilities in General Management, Country leadership roles, Global Strategy and Marketing. Alok holds a Bachelor's of Engineering from Punjab Engineering College in India, and an MBA from American University, Washington, D.C.
Commenting on the appointment, Ms. Vinita Gupta, Chief Executive Officer, and Mr. Nilesh Gupta, Managing Director, Lupin said, "We are delighted to welcome Alok to Lupin. His global experience, strategic perspective, and operational focus will help accelerate our team's efforts to strengthen and evolve our US generics business as we execute on near-term growth opportunities and navigate new platforms in complex generics and biosimilars."
Alok will be based out of Somerset, New Jersey and split his time between Lupin's Somerset, Baltimore and India offices. He will report to Ms. Vinita Gupta - Chief Executive Officer, Lupin and Mr. Nilesh Gupta - Managing Director, Lupin.
Shares of LUPIN LTD. was last trading in BSE at Rs.929.7 as compared to the previous close of Rs. 948.75. The total number of shares traded during the day was 163377 in over 3720 trades.
The stock hit an intraday high of Rs. 963 and intraday low of 927. The net turnover during the day was Rs. 154369841.